Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-18 Sale | 2023-08-22 4:15 pm | GENELUX Corp | GNLX | Cappello Joseph VP, Pharmaceutical Development | 3,265 | $23.73 | $77,478 | 5,735 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-19 Option Award | 2024-07-08 4:30 pm | N/A N/A | GENELUX Corp | GNLX | Cappello Joseph VP, Pharmaceutical Development | 15,218 | $0 | 20,953 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-12 4:23 pm | N/A 2033-09-10 | GENELUX Corp | GNLX | Cappello Joseph VP, Pharmaceutical Development | 65,000 | $0 | 65,000 (Direct) | View |
| 2023-02-17 Option Award | 2023-05-02 4:21 pm | N/A N/A | GENELUX CORP | GNLX | Cappello Joseph VP, Pharmaceutical Development | 9,000 | $0 | 9,000 (Direct) | View |
Ownership | 2023-01-25 7:24 pm | N/A 2025-04-30 | GENELUX CORP | GNLX | Cappello Joseph VP, Pharmaceutical Development | 0 | $0 | 159,999 (Direct) | View |